Chen, E., Brown, D. M., Wong, T. P., Benz, M. S., Kegley, E., Cox, J., . . . Kim, R. Y. (2010). Lucentis(®) using Visudyne(®) study: Determining the threshold-dose fluence of verteporfin photodynamic therapy combined with intravitreal ranibizumab for exudative macular degeneration. Dove Medical Press.
Dyfyniad Arddull ChicagoChen, Eric, David M. Brown, Tien P. Wong, Matthew S. Benz, Eric Kegley, Joel Cox, Richard H. Fish, and Rosa Y. Kim. Lucentis(®) Using Visudyne(®) Study: Determining the Threshold-dose Fluence of Verteporfin Photodynamic Therapy Combined With Intravitreal Ranibizumab for Exudative Macular Degeneration. Dove Medical Press, 2010.
Dyfyniad MLAChen, Eric, et al. Lucentis(®) Using Visudyne(®) Study: Determining the Threshold-dose Fluence of Verteporfin Photodynamic Therapy Combined With Intravitreal Ranibizumab for Exudative Macular Degeneration. Dove Medical Press, 2010.